A detailed history of Ubs Asset Management Americas Inc transactions in Boston Scientific Corp stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 9,129,901 shares of BSX stock, worth $835 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
9,129,901
Previous 9,497,358 3.87%
Holding current value
$835 Million
Previous $731 Million 4.61%
% of portfolio
0.2%
Previous 0.21%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$72.96 - $84.0 $26.8 Million - $30.9 Million
-367,457 Reduced 3.87%
9,129,901 $765 Million
Q2 2024

Aug 13, 2024

BUY
$67.33 - $77.71 $146 Million - $169 Million
2,173,974 Added 29.69%
9,497,358 $731 Million
Q1 2024

May 15, 2024

SELL
$57.6 - $68.62 $35.8 Million - $42.6 Million
-621,344 Reduced 7.82%
7,323,384 $502 Million
Q4 2023

Feb 14, 2024

BUY
$48.64 - $57.81 $13 Million - $15.4 Million
266,715 Added 3.47%
7,944,728 $459 Million
Q3 2023

Nov 13, 2023

BUY
$50.19 - $54.68 $22.2 Million - $24.1 Million
441,622 Added 6.1%
7,678,013 $405 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $41.3 Million - $45.8 Million
-916,301 Reduced 11.24%
7,236,391 $362 Million
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $101 Million - $121 Million
2,555,480 Added 45.66%
8,152,692 $377 Million
Q3 2022

Nov 14, 2022

SELL
$36.71 - $109.66 $1.93 Million - $5.76 Million
-52,481 Reduced 0.93%
5,597,212 $217 Million
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $629,069 - $840,782
-17,851 Reduced 0.31%
5,649,693 $211 Million
Q1 2022

May 16, 2022

SELL
$40.9 - $45.1 $1.08 Million - $1.19 Million
-26,416 Reduced 0.46%
5,667,544 $251 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $25.3 Million - $29.8 Million
-664,364 Reduced 10.45%
5,693,960 $242 Million
Q3 2021

Nov 15, 2021

SELL
$41.23 - $45.88 $14.9 Million - $16.6 Million
-360,758 Reduced 5.37%
6,358,324 $276 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $57.1 Million - $65.5 Million
-1,480,581 Reduced 18.06%
6,719,082 $287 Million
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $16 Million - $18 Million
453,168 Added 5.85%
8,199,663 $317 Million
Q4 2020

Mar 01, 2021

BUY
$33.15 - $41.97 $25.9 Million - $32.8 Million
780,919 Added 11.21%
7,746,495 $278 Million
Q3 2020

Nov 13, 2020

BUY
$34.44 - $42.23 $7.97 Million - $9.77 Million
231,354 Added 3.44%
6,965,576 $266 Million
Q2 2020

Aug 14, 2020

BUY
$30.19 - $39.11 $42.4 Million - $54.9 Million
1,404,025 Added 26.34%
6,734,222 $236 Million
Q1 2020

May 15, 2020

BUY
$25.83 - $45.71 $22.9 Million - $40.6 Million
887,942 Added 19.99%
5,330,197 $174 Million
Q4 2019

Feb 14, 2020

BUY
$37.87 - $45.37 $2.1 Million - $2.51 Million
55,369 Added 1.26%
4,442,255 $201 Million
Q3 2019

Nov 14, 2019

BUY
$40.31 - $43.45 $8.68 Million - $9.36 Million
215,309 Added 5.16%
4,386,886 $179 Million
Q2 2019

Aug 15, 2019

SELL
$34.91 - $42.98 $4.11 Million - $5.06 Million
-117,665 Reduced 2.74%
4,171,577 $0
Q1 2019

May 14, 2019

BUY
$32.91 - $40.75 $124,695 - $154,401
3,789 Added 0.09%
4,289,242 $0
Q4 2018

Feb 13, 2019

BUY
$31.73 - $39.04 $5.78 Million - $7.12 Million
182,308 Added 4.44%
4,285,453 $151 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $114,478 - $134,702
3,487 Added 0.09%
4,103,145 $0
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $2.58 Million - $3.3 Million
-96,195 Reduced 2.29%
4,099,658 $0
Q1 2018

May 14, 2018

BUY
$25.2 - $28.54 $12.4 Million - $14 Million
492,287 Added 13.29%
4,195,853 $0
Q4 2017

Feb 09, 2018

BUY
$24.79 - $29.8 $772,729 - $928,895
31,171 Added 0.85%
3,703,566 $0
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $96.4 Million - $107 Million
3,672,395
3,672,395 $0

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.